Clinical Trial Update: Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial by Mayo Clinic evaluating targeting pathways in polycystic ovary syndrome using metformin; status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Mayo Clinic | Conditions: Polycystic Ovary Syndrome | Phase 1 | Status: COMPLETED